The first successful pediatric heart transplant and results from the earliest era

Richard Kirk1, Ryan J Butts1, Anne I Dipchand2

  • 1Children's Medical Center, Dallas, Texas.

Insights

Early pediatric heart transplants before 1982 had limited survival, with many patients requiring retransplantation. This foundational experience in pediatric heart transplantation paved the way for future advancements.

Area of Science:

  • Pediatric Cardiology
  • Transplant Surgery
  • Medical History

Background:

  • Limited historical data exists on early pediatric heart transplant outcomes before 1982.
  • This study retrospectively analyzes data from the International Society for Heart and Lung Transplantation (ISHLT) Registry.

Observation:

  • Thirty pediatric patients underwent heart transplantation before 1982, with a median age of 13 years.
  • Cardiomyopathy and congenital heart disease were the primary diagnoses.
  • The median follow-up was 2.63 years, with 22 deaths and 8 retransplantations.

Findings:

  • Median patient survival was 3.5 years.
  • The first child to survive over a year post-transplant received the procedure in 1968 and lived for 6 years.
  • Early survival rates were significantly lower compared to later eras, with higher rates of retransplantation.

Implications:

  • The management of these early pediatric heart transplant recipients provided crucial insights for improving future transplant protocols.
  • This historical analysis highlights the evolution of pediatric heart transplantation and its long-term impact.
Abstract

Related Concept Videos

Ecological Succession02:17

Ecological Succession

Ecological succession is influenced by the processes of facilitation, inhibition, and toleration. Facilitation occurs when early successional species create more favorable ecological conditions for subsequent species, such as enhanced nutrient, water, or light availability. In contrast, inhibition happens when early successional species create unfavorable ecological conditions for potential successive species, such as limiting resource availability. In some cases, later successional species...
21.5K
Anatomy of the Heart01:27

Anatomy of the Heart

The human heart is made up of three layers of tissue that are surrounded by the pericardium, a membrane that protects and confines the heart. The outermost layer, closest to the pericardium, is the epicardium. The pericardial cavity separates the pericardium from the epicardium. Beneath the epicardium is the myocardium, the middle layer, and the endocardium, the innermost layer. There are four chambers of the heart: the right atrium, the right ventricle, the left atrium, and the left ventricle.
119.7K
Anatomy of the Heart01:20

Anatomy of the Heart

The heart is a hollow, muscular organ approximately the size of a fist, consisting of four chambers. It is enclosed in the pericardium, a fibrous sac with two layers: the visceral and parietal pericardium, separated by a fluid-filled space containing serous fluid to reduce friction.
The heart has three layers: the innermost endocardium, the muscular myocardium, and the outer epicardium, all working together for optimal cardiac function.
Chambers of the Heart
The heart is made up of four...
3.1K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
259
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
304
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
223